Cargando…
Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases
BACKGROUND: Recurrence of breast cancer after treatment is generally due to loco-regional invasion or distant metastasis. Although patients with metastasis are considered incurable, existing treatments might prolong a patient’s life while also improving its quality. Choice of approach for individual...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031793/ https://www.ncbi.nlm.nih.gov/pubmed/29693352 http://dx.doi.org/10.22034/APJCP.2018.19.4.949 |
_version_ | 1783337386026991616 |
---|---|
author | Akbari, Mohammad Esmaeil Rohani-Rasaf, Marzieh Nafissi, Nahid Akbari, Atieh Shojaee, Leyla |
author_facet | Akbari, Mohammad Esmaeil Rohani-Rasaf, Marzieh Nafissi, Nahid Akbari, Atieh Shojaee, Leyla |
author_sort | Akbari, Mohammad Esmaeil |
collection | PubMed |
description | BACKGROUND: Recurrence of breast cancer after treatment is generally due to loco-regional invasion or distant metastasis. Although patients with metastasis are considered incurable, existing treatments might prolong a patient’s life while also improving its quality. Choice of approach for individual patients requires identification of relevant survival factors. This study concerns factors influencing survival after recurrence in Iranian breast cancer patients. METHODS: This study was performed on 442 recurrent breast cancer patients referred to the Cancer Research Center of Shahid Beheshti University between 1985 and 2015. After confirming recurrence as a distant metastasis or loco-regional invasion, the effects of demographic, clinic-pathologic, biological, type of surgery and type of adjuvant treatment on survival were evaluated using univariate and multivariate stratified Cox models. RESULTS: The mean survival after recurrence was 18 months (5 days to 13 years), 219 patients (70.42%) survived two years, 75 patients (24.12%) survived from 2 to 5 years, and 17 patients (5.47%) survived more than 5 years. In this study, it was found through univariate analysis that the factors of age, lymph node status, DFI, place of recurrence and nodal ratio demonstrated greatest influence on survival after recurrence. On multivariate analysis, the most important factors influencing survival were the place of recurrence and the lymph node status. CONCLUSION: The results of this study enhance our knowledge of effects of different factors on survival of patients after breast cancer recurrence. Thus, they may be used to inform treatment choice. |
format | Online Article Text |
id | pubmed-6031793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-60317932018-07-11 Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases Akbari, Mohammad Esmaeil Rohani-Rasaf, Marzieh Nafissi, Nahid Akbari, Atieh Shojaee, Leyla Asian Pac J Cancer Prev Research Article BACKGROUND: Recurrence of breast cancer after treatment is generally due to loco-regional invasion or distant metastasis. Although patients with metastasis are considered incurable, existing treatments might prolong a patient’s life while also improving its quality. Choice of approach for individual patients requires identification of relevant survival factors. This study concerns factors influencing survival after recurrence in Iranian breast cancer patients. METHODS: This study was performed on 442 recurrent breast cancer patients referred to the Cancer Research Center of Shahid Beheshti University between 1985 and 2015. After confirming recurrence as a distant metastasis or loco-regional invasion, the effects of demographic, clinic-pathologic, biological, type of surgery and type of adjuvant treatment on survival were evaluated using univariate and multivariate stratified Cox models. RESULTS: The mean survival after recurrence was 18 months (5 days to 13 years), 219 patients (70.42%) survived two years, 75 patients (24.12%) survived from 2 to 5 years, and 17 patients (5.47%) survived more than 5 years. In this study, it was found through univariate analysis that the factors of age, lymph node status, DFI, place of recurrence and nodal ratio demonstrated greatest influence on survival after recurrence. On multivariate analysis, the most important factors influencing survival were the place of recurrence and the lymph node status. CONCLUSION: The results of this study enhance our knowledge of effects of different factors on survival of patients after breast cancer recurrence. Thus, they may be used to inform treatment choice. West Asia Organization for Cancer Prevention 2018 /pmc/articles/PMC6031793/ /pubmed/29693352 http://dx.doi.org/10.22034/APJCP.2018.19.4.949 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Research Article Akbari, Mohammad Esmaeil Rohani-Rasaf, Marzieh Nafissi, Nahid Akbari, Atieh Shojaee, Leyla Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases |
title | Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases |
title_full | Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases |
title_fullStr | Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases |
title_full_unstemmed | Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases |
title_short | Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases |
title_sort | effecst of patho- biological factors on the survival of recurrent breast cancer cases |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031793/ https://www.ncbi.nlm.nih.gov/pubmed/29693352 http://dx.doi.org/10.22034/APJCP.2018.19.4.949 |
work_keys_str_mv | AT akbarimohammadesmaeil effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases AT rohanirasafmarzieh effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases AT nafissinahid effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases AT akbariatieh effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases AT shojaeeleyla effecstofpathobiologicalfactorsonthesurvivalofrecurrentbreastcancercases |